Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Social domains of discrimination against people who inject drugs: Links with health and wellbeing.

Couto E Cruz C, Salom C, Parsell C, Dietze P, Burns L, Alati R.

Int J Drug Policy. 2020 Jan 10;77:102620. doi: 10.1016/j.drugpo.2019.102620. [Epub ahead of print]

PMID:
31931474
2.

Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia.

Gibbs D, Peacock A, O'Keefe D, Butler K, Bruno R, Lenton S, Burns L, Larney S.

Drug Alcohol Rev. 2020 Jan;39(1):83-92. doi: 10.1111/dar.13006. Epub 2019 Dec 11.

PMID:
31828864
3.

From eye rolls to punches: experiences of harm from others' drinking among risky-drinking adolescents across Australia.

Lam T, Laslett AM, Ogeil RP, Lubman DI, Liang W, Chikritzhs TN, Gilmore WG, Lenton SR, Fischer J, Aiken A, Mattick RP, Burns LA, Midford R, Allsop SJ.

Public Health Res Pract. 2019 Dec 4;29(4). pii: 2941927. doi: 10.17061/phrp2941927.

4.

Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use.

Todd G, Burns L, Pearson-Dennett V, Esterman A, Faulkner PL, Wilcox RA, Thewlis D, Vogel AP, White JM.

Drug Alcohol Depend. 2019 Dec 1;205:107595. doi: 10.1016/j.drugalcdep.2019.107595. Epub 2019 Sep 27.

PMID:
31600615
5.

Mother-Infant Bonding and Emotional Availability at 12-Months of Age: The Role of Early Postnatal Bonding, Maternal Substance Use and Mental Health.

Rossen L, Mattick RP, Wilson J, Clare PJ, Burns L, Allsop S, Elliott EJ, Jacobs S, Olsson CA, Hutchinson D.

Matern Child Health J. 2019 Dec;23(12):1686-1698. doi: 10.1007/s10995-019-02809-1.

PMID:
31529248
6.

Correction to: Prenatal alcohol exposure and infant gross motor development: a prospective cohort study.

Hutchinson D, Youssef GJ, McCormack C, Wilson J, Allsop S, Najman J, Elliott E, Burns L, Jacobs S, Honan I, Rossen L, Fiedler H, Teague S, Ryan J, Olsson CA, Mattick RP.

BMC Pediatr. 2019 Jul 4;19(1):222. doi: 10.1186/s12887-019-1585-5.

7.

Prenatal alcohol exposure and infant gross motor development: a prospective cohort study.

Hutchinson D, Youssef GJ, McCormack C, Wilson J, Allsop S, Najman J, Elliott E, Burns L, Jacobs S, Honan I, Rossen L, Fiedler H, Teague S, Ryan J, Olsson CA, Mattick RP.

BMC Pediatr. 2019 May 14;19(1):149. doi: 10.1186/s12887-019-1516-5. Erratum in: BMC Pediatr. 2019 Jul 4;19(1):222.

8.

The association between experiencing discrimination and physical and mental health among people who inject drugs.

Couto E Cruz C, Salom CL, Dietze P, Burns L, Alati R.

Int J Drug Policy. 2019 Mar;65:24-30. doi: 10.1016/j.drugpo.2018.12.010. Epub 2018 Dec 24.

PMID:
30590304
9.

Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system.

Butler K, Larney S, Day CA, Burns L.

Drug Alcohol Rev. 2019 Mar;38(3):264-269. doi: 10.1111/dar.12883. Epub 2018 Dec 12.

PMID:
30548702
10.

Insomnia and Regulation of Sleep-Wake Cycle With Drugs Among Adolescent Risky Drinkers.

Lam T, Ogeil RP, Allsop S, Chikritzhs T, Fischer J, Midford R, Gilmore W, Lenton S, Liang W, Lloyd B, Aiken A, Mattick R, Burns L, Lubman DI.

J Clin Sleep Med. 2018 Sep 15;14(9):1529-1537. doi: 10.5664/jcsm.7330.

11.

Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing.

Couto E Cruz C, Salom CL, Dietze P, Lenton S, Burns L, Alati R.

Drug Alcohol Depend. 2018 Sep 1;190:188-194. doi: 10.1016/j.drugalcdep.2018.06.009. Epub 2018 Jul 19.

PMID:
30048872
12.

Typology of new psychoactive substance use among the general Australian population.

Sutherland R, Peacock A, Roxburgh A, Barratt MJ, Burns L, Bruno R.

Drug Alcohol Depend. 2018 Jul 1;188:126-134. doi: 10.1016/j.drugalcdep.2018.03.034. Epub 2018 May 3.

PMID:
29775956
13.

Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities.

Dietze PM, Stare M, Cogger S, Nambiar D, Olsen A, Burns L, Lenton S.

Drug Alcohol Rev. 2018 May;37(4):457-463. doi: 10.1111/dar.12644. Epub 2017 Dec 21.

PMID:
29744979
14.

A managed alcohol program in Sydney, Australia: Acceptability, cost-savings and non-beverage alcohol use.

Ezard N, Cecilio ME, Clifford B, Baldry E, Burns L, Day CA, Shanahan M, Dolan K.

Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S184-S194. doi: 10.1111/dar.12702. Epub 2018 Apr 17.

PMID:
29665174
15.

Accurate identification of opioid overdose deaths using coronial data.

Roxburgh A, Pilgrim JL, Hall WD, Burns L, Degenhardt L.

Forensic Sci Int. 2018 Jun;287:40-46. doi: 10.1016/j.forsciint.2018.03.032. Epub 2018 Mar 26.

PMID:
29627712
16.

Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort Study.

Peacock A, Hutchinson D, Wilson J, McCormack C, Bruno R, Olsson CA, Allsop S, Elliott E, Burns L, Mattick RP.

Nutrients. 2018 Mar 7;10(3). pii: E319. doi: 10.3390/nu10030319.

17.

Cohort Profile: The Triple B Pregnancy Cohort Study: A longitudinal study of the relationship between alcohol, tobacco and other substance use during pregnancy and the health and well-being of Australian children and families.

Hutchinson D, Wilson J, Allsop S, Elliott E, Najman J, Burns L, Bartu A, Jacobs S, Honan I, McCormack C, Rossen L, Fiedler H, Stone C, Khor S, Ryan J, J Youssef G, A Olsson C, P Mattick R; Triple B Research Consortium.

Int J Epidemiol. 2018 Feb 1;47(1):26-27m. doi: 10.1093/ije/dyx126. No abstract available.

PMID:
29087498
18.

Trends in heroin and pharmaceutical opioid overdose deaths in Australia.

Roxburgh A, Hall WD, Dobbins T, Gisev N, Burns L, Pearson S, Degenhardt L.

Drug Alcohol Depend. 2017 Oct 1;179:291-298. doi: 10.1016/j.drugalcdep.2017.07.018. Epub 2017 Aug 14.

PMID:
28826104
19.

Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in Australia.

Butler K, Day C, Sutherland R, van Buskirk J, Breen C, Burns L, Larney S.

Int J Drug Policy. 2017 Sep;47:102-106. doi: 10.1016/j.drugpo.2017.07.008. Epub 2017 Aug 5.

PMID:
28789820
20.

How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?

O'Keefe D, McCormack A, Cogger S, Aitken C, Burns L, Bruno R, Stafford J, Butler K, Breen C, Dietze P.

Int J Drug Policy. 2017 Aug;46:99-106. doi: 10.1016/j.drugpo.2017.05.055. Epub 2017 Jun 28.

PMID:
28667880

Supplemental Content

Loading ...
Support Center